D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 43 Citations 9,221 219 World Ranking 16577 National Ranking 472

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Disease
  • Bacteria

Claire E. Wainwright spends much of her time researching Cystic fibrosis, Microbiology, Pseudomonas aeruginosa, Internal medicine and Randomized controlled trial. The various areas that Claire E. Wainwright examines in her Cystic fibrosis study include Lung and Immunology. Her Microbiology research incorporates themes from Pseudomonadaceae, Pulsed-field gel electrophoresis, Molecular typing, Polymerase chain reaction and Virulence.

Her Pseudomonas aeruginosa research incorporates elements of Sputum, Strain, Genotype and Pathology. Her Internal medicine research integrates issues from Gastroenterology and Surgery. Her Randomized controlled trial research is multidisciplinary, incorporating elements of Bronchiolitis and Anesthesia.

Her most cited work include:

  • A CFTR potentiator in patients with cystic fibrosis and the G551D mutation (1372 citations)
  • Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation (325 citations)
  • Nebulised hypertonic saline solution for acute bronchiolitis in infants (273 citations)

What are the main themes of her work throughout her whole career to date?

Claire E. Wainwright focuses on Cystic fibrosis, Internal medicine, Pseudomonas aeruginosa, Microbiology and Gastroenterology. Claire E. Wainwright works mostly in the field of Cystic fibrosis, limiting it down to topics relating to Bronchoalveolar lavage and, in certain cases, Bronchiectasis. Her Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Surgery.

In her work, Gene mutation is strongly intertwined with Antibiotic resistance, which is a subfield of Pseudomonas aeruginosa. Her Microbiology research is multidisciplinary, incorporating perspectives in Stenotrophomonas maltophilia, Pulsed-field gel electrophoresis, Mycobacterium abscessus and Gene, Virulence. Her work on Lumacaftor as part of general Ivacaftor study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.

She most often published in these fields:

  • Cystic fibrosis (72.42%)
  • Internal medicine (36.36%)
  • Pseudomonas aeruginosa (35.15%)

What were the highlights of her more recent work (between 2018-2021)?

  • Cystic fibrosis (72.42%)
  • Internal medicine (36.36%)
  • Ivacaftor (9.70%)

In recent papers she was focusing on the following fields of study:

Her main research concerns Cystic fibrosis, Internal medicine, Ivacaftor, Gastroenterology and In patient. Claire E. Wainwright has researched Cystic fibrosis in several fields, including Body mass index, Bronchiectasis, Mutation, Pseudomonas aeruginosa and Lung function. Her Pseudomonas aeruginosa research includes themes of Antibiotic resistance, Carbapenem and Increased risk.

Her studies in Ivacaftor integrate themes in fields like Discontinuation and Phases of clinical research. Her Cystic fibrosis transmembrane conductance regulator study which covers Tolerability that intersects with Interim analysis. Claire E. Wainwright has included themes like Lung and Atelectasis in her Clinical research study.

Between 2018 and 2021, her most popular works were:

  • Aspergillus and progression of lung disease in children with cystic fibrosis. (20 citations)
  • Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1. (17 citations)
  • Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei (15 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Bacteria

Her primary areas of study are Internal medicine, Cystic fibrosis, Gastroenterology, Ivacaftor and Bronchoalveolar lavage. Her biological study spans a wide range of topics, including Phenotype, Aspergillus and Empyema. Her Cystic fibrosis study integrates concerns from other disciplines, such as Microbiology, Bacteria, Staphylococcus aureus and Transmission, Infection transmission.

Her Gastroenterology study combines topics in areas such as Discontinuation and Mutation. Her Ivacaftor study incorporates themes from Clinical endpoint, Adverse effect and Phases of clinical research. Her study in Bronchoalveolar lavage is interdisciplinary in nature, drawing from both Pseudomonas aeruginosa, Fungal pathogen, Positive culture and Bronchiectasis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

Bonnie W. Ramsey;Jane Davies;N. Gerard McElvaney;Elizabeth Tullis.
The New England Journal of Medicine (2011)

2088 Citations

Nebulised hypertonic saline solution for acute bronchiolitis in infants

Linjie Zhang;Raúl A Mendoza-Sassi;Claire Wainwright;Terry P Klassen.
Cochrane Database of Systematic Reviews (2013)

652 Citations

Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation

Jane C. Davies;Jane C. Davies;Claire E. Wainwright;Gerard J. Canny;Mark A. Chilvers.
American Journal of Respiratory and Critical Care Medicine (2013)

493 Citations

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

Josephine M Bryant;Josephine M Bryant;Dorothy M Grogono;Dorothy M Grogono;Daniela Rodriguez-Rincon;Isobel Everall.
Science (2016)

416 Citations

Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection

Alexandra L. Quittner;Avani C. Modi;Claire Wainwright;Kelly Otto.
Chest (2009)

350 Citations

A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis.

Claire Wainwright;Luis Altamirano;Marise Cheney;Joyce Cheney.
The New England Journal of Medicine (2003)

307 Citations

Genetic modifiers of liver disease in cystic fibrosis.

Jaclyn R. Bartlett;Kenneth J. Friedman;Simon C. Ling;Rhonda G. Pace.
JAMA (2009)

282 Citations

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled, phase 3 trial

Felix Ratjen;Christopher Hug;Gautham Marigowda;Simon Tian.
The Lancet Respiratory Medicine (2017)

257 Citations

Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: A randomized trial

Claire E. Wainwright;Suzanna Vidmar;David S. Armstrong;Catherine A. Byrnes.
JAMA (2011)

200 Citations

Nebulized hypertonic saline solution for acute bronchiolitis in infants: [Intervention Review]

Linjie Zhang;Raul A. Mendoza-Sassi;Claire Wainwright;Terry P. Klassen.
Cochrane Database of Systematic Reviews (2009)

185 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Claire E. Wainwright

Scott C. Bell

Scott C. Bell

University of Queensland

Publications: 93

Felix Ratjen

Felix Ratjen

University of Toronto

Publications: 75

John P. Clancy

John P. Clancy

Cystic Fibrosis Foundation

Publications: 60

Anne B. Chang

Anne B. Chang

Boston Children's Hospital

Publications: 57

Stephen M. Stick

Stephen M. Stick

University of Western Australia

Publications: 56

Margaret Rosenfeld

Margaret Rosenfeld

University of Washington

Publications: 50

Andrew Bush

Andrew Bush

National Institutes of Health

Publications: 50

J. Stuart Elborn

J. Stuart Elborn

Queen's University Belfast

Publications: 46

Marcus A. Mall

Marcus A. Mall

Charité - University Medicine Berlin

Publications: 41

Michael W. Konstan

Michael W. Konstan

Case Western Reserve University

Publications: 39

Laurent Kremer

Laurent Kremer

Institut de Recherche en Infectiologie de Montpellier (IRIM)

Publications: 33

Bonnie W. Ramsey

Bonnie W. Ramsey

University of Washington

Publications: 32

Peter D. Sly

Peter D. Sly

University of Queensland

Publications: 31

Margarida D. Amaral

Margarida D. Amaral

University of Lisbon

Publications: 30

Andrew Jones

Andrew Jones

University of East Anglia

Publications: 28

Garry R. Cutting

Garry R. Cutting

Johns Hopkins University School of Medicine

Publications: 26

Trending Scientists

Benjamin Schlein

Benjamin Schlein

University of Zurich

Lorenzo Stievano

Lorenzo Stievano

Centre national de la recherche scientifique, CNRS

Seiya Kobatake

Seiya Kobatake

Osaka Metropolitan University

Marco Crisma

Marco Crisma

University of Padua

Laure Guillou

Laure Guillou

Université Paris Cité

J. Le Dividich

J. Le Dividich

INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement

Tsvee Lapidot

Tsvee Lapidot

Weizmann Institute of Science

Margarita Medina

Margarita Medina

Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria

Paul M. Sondel

Paul M. Sondel

University of Wisconsin–Madison

Pierre E. Biscaye

Pierre E. Biscaye

Lamont-Doherty Earth Observatory

Martin R. Stämpfli

Martin R. Stämpfli

McMaster University

William Stohl

William Stohl

University of Southern California

Alan S. Bellack

Alan S. Bellack

University of Maryland, Baltimore

Leonard E. Egede

Leonard E. Egede

Medical College of Wisconsin

Adel K. El-Naggar

Adel K. El-Naggar

The University of Texas MD Anderson Cancer Center

Adnan Kastrati

Adnan Kastrati

Technical University of Munich

Something went wrong. Please try again later.